Journal of Experimental & Clinical Cancer Research 2009, 28:115 http://www.jeccr.com/content/28/1/115 Genetic variation in TP53 and risk of breast cancer in a pop- ulation-based case control study. Carcinogenesis 2007, 28:1680-1686. 58. Akkiprik M, Sonmez O, Gulluoglu BM, Caglar HB, Kaya H, Demirka- lem P, Abacioglu U, Sengoz M, Sav A, Ozer A: Analysis of p53 Gene Polymorphisms and Protein Over-expression in Patients with Breast Cancer. Pathol Oncol Res 2008. DOI:10.1007/s12253- 008-9129-6. 59. Zhang W, Jin MJ, Chen K: Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer. Zhe- jiang Da Xue Xue Bao Yi Xue Ban 2007, 36:561-566. 60. Tobias A: Assessing the influence of a single study in the meta- analysis estimate. Stata Techn Bull 1999, 8:15-17. 61. Koushik A, Platt RW, Franco EL: p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epide- miol Biomarkers Prev 2004, 13:11-22. 62. Jee SH, Won SY, Yun JE, Lee JE, Park JS, Ji SS: Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. Int J Gynaecol Obstet 2004, 85:301-308. 63. Sousa H, Santos AM, Pinto D, Medeiros R: Is the p53 codon 72 pol- ymorphism a key biomarker for cervical cancer develop- ment? A meta-analysis review within European populations. Int J Mol Med 2007, 20:731-741. 64. Matakidou A, Eisen T, Houlston RS: TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003, 18:377-85. 65. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT: P53 codon 72 polymorphism and gastric cancer: a meta- analysis of the literature. Int J Cancer 2007, 121:1481-1486. 66. Li Y, Qiu LX, Shen XK, Lv XJ, Qian XP, Song Y: A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: Evidence from 15,857 subjects. Lung Cancer 2009. 67. Pietsch EC, Humbey O, Murphy ME: Polymorphisms in the p53 pathway. Oncogene 2006, 25:1602-1611. 68. Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M: The codon 72 polymorphic variants of p53 have markedly differ- ent apoptotic potential. Nat Genet 2003, 33:357-365. 69. Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai HD, Lin CC: The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril 2002, 77:43-45. 70. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS: Per- sistent human papillomavirus infection and cervical neopla- sia: a systematic review and meta-analysis. Am J Epidemiol 2008, 168:123-137. 71. Miller CS, Johnstone BM: Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982– 1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91:622-635. 72. Amarante MK, Watanabe MA: The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol 2009, 135:329-337. 73. Munafò MR, Flint J: Meta-analysis of genetic association studies. Trends Genet 2004, 20(9):439-444. Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 9 of 9 (page number not for citation purposes)